Mylan Joins Firms Facing DOJ Probe On Price Hikes; Senate Plans Industry-Free Hearing
This article was originally published in The Pink Sheet Daily
Executive Summary
Senate Special Aging Committee hearing Wednesday to focus on price spikes in off-patent drugs without testimony from drug makers.
You may also be interested in...
US Price-Fixing Litigation Presses On With 'Overarching Conspiracy' Claims Intact
Judge allows plaintiffs to argue attendance at trade association meetings and job-hopping show scheme to fix drug prices; confidentiality of attorney communication is in dispute.
Generic Price Fixing Litigation Presses On With 'Overarching Conspiracy' Claims Intact
Judge allows plaintiffs to argue attendance at trade association meetings and job-hopping show scheme to fix drug prices; confidentiality of attorney communication is in dispute.
Generic Industry Hit With Avalanche Of Price Fixing Suits
As state attorneys general and Department of Justice move against generic manufacturers, plaintiffs’ firms have filed more than 90 antitrust suits on behalf of third party payers.